Deletion of Braun Lipoprotein and Plasminogen-Activating Protease-Encoding Genes Attenuates Yersinia pestis in Mouse Models of Bubonic and Pneumonic Plague

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Infection and Immunity

• Publication date

  2014-03-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.01595-13PMID 24686064PMCID PMC4019162
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Yersinia pestis and the plague of Justinian 541-543 AD: a genomic analysis.

  2014cited by this paper
• The Effects of Modeled Microgravity on Growth Kinetics, Antibiotic Susceptibility, Cold Growth, and the Virulence Potential of a Yersinia pestis ymoA-Deficient Mutant and Its Isogenic Parental Strain

  2013cited by this paper
• Multiple antigen peptide consisting of B- and T-cell epitopes of F1 antigen of Y. pestis showed enhanced humoral and mucosal immune response in different strains of mice.

  2013cited by this paper
• Fibrin Facilitates Both Innate and T Cell–Mediated Defense against Yersinia pestis

  2013influential reference
• Mutated and Bacteriophage T4 Nanoparticle Arrayed F1-V Immunogens from Yersinia pestis as Next Generation Plague Vaccines

  2013cited by this paper
• Substrates of the plasminogen activator protease of Yersinia pestis.

  2012cited by this paper
• Plague vaccines: current developments and future perspectives

  2012influential reference
• Deletion of the Braun Lipoprotein-Encoding Gene and Altering the Function of Lipopolysaccharide Attenuate the Plague Bacterium

  2012cited by this paper
• IL-17 Contributes to Cell-Mediated Defense against Pulmonary Yersinia pestis Infection

  2011influential reference
• Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague.

  2011cited by this paper
• Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines.

  2011cited by this paper
• An additional step in the transmission of Yersinia pestis?

  2011cited by this paper
• Progress on plague vaccine development

  2011cited by this paper
• Deciphering the role of Th17 cells in human disease.

  2011cited by this paper
• Deletion of Braun lipoprotein gene (lpp) attenuates Yersinia pestis KIM/D27 strain: role of Lpp in modulating host immune response, NF-kappaB activation and cell death.

  2010cited by this paper
• Mucosal Vaccination with a Multivalent, Live-Attenuated Vaccine Induces Multifactorial Immunity against Pseudomonas aeruginosa Acute Lung Infection

  2010cited by this paper
• Comparative Global Gene Expression Profiles of Wild-Type Yersinia pestis CO92 and Its Braun Lipoprotein Mutant at Flea and Human Body Temperatures

  2010cited by this paper
• The physiologic responses of Dutch belted rabbits infected with inhalational anthrax.

  2009cited by this paper
• Interleukin-17 and type 17 helper T cells.

  2009cited by this paper
• Plague as a Biological Weapon

  2009cited by this paper
• Deletion of Braun lipoprotein gene (lpp) and curing of plasmid pPCP1 dramatically alter the virulence of Yersinia pestis CO92 in a mouse model of pneumonic plague.

  2009cited by this paper
• Antibodies and cytokines independently protect against pneumonic plague.

  2008cited by this paper
• Current challenges in the development of vaccines for pneumonic plague

  2008influential reference
• Immune defense against pneumonic plague

  2008cited by this paper
• Braun Lipoprotein (Lpp) Contributes to Virulence of Yersiniae: Potential Role of Lpp in Inducing Bubonic and Pneumonic Plague

  2008cited by this paper
• Resistance of Yersinia pestis to Complement-Dependent Killing Is Mediated by the Ail Outer Membrane Protein

  2007cited by this paper
• A Plasminogen-Activating Protease Specifically Controls the Development of Primary Pneumonic Plague

  2007cited by this paper
• The Genus Yersinia

  2007cited by this paper
• Using every trick in the book: the Pla surface protease of Yersinia pestis.

  2007cited by this paper
• Evaluation of combinatorial vaccines against anthrax and plague in a murine model.

  2007cited by this paper
• Current trends in plague research: from genomics to virulence.

  2006cited by this paper
• Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague.

  2006cited by this paper
• Plague: a review of its history and potential as a biological weapon.

  2006cited by this paper
• An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants

  2005cited by this paper
• Pathogenesis of Yersinia pestis Infection in BALB/c Mice: Effects on Host Macrophages and Neutrophils

  2005cited by this paper
• Human Immune Response to a Plague Vaccine Comprising Recombinant F1 and V Antigens

  2005cited by this paper
• Modulation of Yersinia Type Three Secretion System by the S1 Domain of Polynucleotide Phosphorylase*

  2005influential reference
• The Two Murein Lipoproteins of Salmonella enterica Serovar Typhimurium Contribute to the Virulence of the Organism

  2004cited by this paper
• Bmc Microbiology

  2004cited by this paper
• Expression

  2003cited by this paper
• Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo.

  2002cited by this paper
• Genome sequence of Yersinia pestis, the causative agent of plague

  2001cited by this paper
• Vaccination against bubonic and pneumonic plague.

  2001influential reference
• Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

  2000cited by this paper
• Plague as Biological Weapon

  2000cited by this paper
• One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

  2000cited by this paper
• Metapopulation dynamics of bubonic plague

  2000cited by this paper
• Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2.

  1999influential reference
• Expression of Plasminogen Activator Pla ofYersinia pestis Enhances Bacterial Attachment to the Mammalian Extracellular Matrix

  1998cited by this paper
• Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression.

  1998cited by this paper
• Yersinia pestis--etiologic agent of plague

  1997cited by this paper
• Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis.

  1997cited by this paper
• Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies

  1995cited by this paper
• Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona.

  1994cited by this paper
• A surface protease and the invasive character of plague.

  1992cited by this paper
• A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR

  1988cited by this paper
• Genetic analysis of the 9.5-kilobase virulence plasmid of Yersinia pestis

  1988cited by this paper
• Effectiveness of live or killed plague vaccines in man.

  1970cited by this paper

• Live Plague Vaccine Development: Past, Present, and Future

  2025cites this paper
• Progress on the research and development of plague vaccines with a call to action

  2024cites this paper
• PgtE Enzyme of Salmonella enterica Shares the Similar Biological Roles to Plasminogen Activator (Pla) in Interacting With DEC-205 (CD205), and Enhancing Host Dissemination and Infectivity by Yersinia pestis

  2022cites this paper
• Plague vaccines: new developments in an ongoing search

  2021cites this paper
• Deaths Associated with Pneumonic Plague, 1946–2017

  2020cites this paper
• Superbugs, silver bullets, and new battlefields

  2020cites this paper
• Современное состояние проблемы разработки вакцин для специфической профилактики чумы

  2019cites this paper
• The rise of pneumonic plague in Madagascar: current plague outbreak breaks usual seasonal mould

  2019cites this paper
• Interplay between Peptidoglycan Biology and Virulence in Gram-Negative Pathogens

  2018cites this paper
• Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics

  2017influential citation
• Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis

  2017influential citation
• Prediction of vaccine candidates against Pseudomonas aeruginosa: An integrated genomics and proteomics approach.

  2017cites this paper
• Protective Immunity Elicited by Oral Immunization of Mice with Salmonella enterica Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) Mutants

  2016cites this paper
• Escherichia coli Braun Lipoprotein (BLP) exhibits endotoxemia – like pathology in Swiss albino mice

  2016cites this paper
• A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates

  2016cites this paper
• New Insights into Autoinducer-2 Signaling as a Virulence Regulator in a Mouse Model of Pneumonic Plague

  2016cites this paper
• Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague

  2016influential citation
• Bacterial pathogens activate plasminogen to breach tissue barriers and escape from innate immunity

  2016cites this paper
• Identification of Host and Bacterial Factors that Contribute to Lung Lesion Structure during Pneumonic Plague

  2015cites this paper
• Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague

  2015cites this paper
• Further characterization of a highly attenuated Yersinia pestis CO92 mutant deleted for the genes encoding Braun lipoprotein and plasminogen activator protease in murine alveolar and primary human macrophages.

  2015cites this paper
• Combinational Deletion of Three Membrane Protein-Encoding Genes Highly Attenuates Yersinia pestis while Retaining Immunogenicity in a Mouse Model of Pneumonic Plague

  2015cites this paper
• Deletion of luxS further attenuates the virulence of the avian pathogenic Escherichia coli aroA mutant.

  2015cites this paper
• High-Throughput, Signature-Tagged Mutagenic Approach To Identify Novel Virulence Factors of Yersinia pestis CO92 in a Mouse Model of Infection

  2015influential citation
• Escherichia coli lipoprotein binds human plasminogen via an intramolecular domain

  2015cites this paper
• HSP70 Domain II of Mycobacterium tuberculosis Modulates Immune Response and Protective Potential of F1 and LcrV Antigens of Yersinia pestis in a Mouse Model

  2014cites this paper